Franchises et coassurance : Questions médicales fréquentes
Nom anglais: Deductibles and Coinsurance
Descriptor UI:D003669
Tree Number:N03.219.521.576.090.300
Termes MeSH sélectionnés :
Bronchial Hyperreactivity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Franchises et coassurance : Questions médicales les plus fréquentes",
"headline": "Franchises et coassurance : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Franchises et coassurance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-08",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Franchises et coassurance"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Participation aux coûts",
"url": "https://questionsmedicales.fr/mesh/D017047",
"about": {
"@type": "MedicalCondition",
"name": "Participation aux coûts",
"code": {
"@type": "MedicalCode",
"code": "D017047",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.521.576.090"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Franchises et coassurance",
"alternateName": "Deductibles and Coinsurance",
"code": {
"@type": "MedicalCode",
"code": "D003669",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Frank Wharam",
"url": "https://questionsmedicales.fr/author/J%20Frank%20Wharam",
"affiliation": {
"@type": "Organization",
"name": "Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA."
}
},
{
"@type": "Person",
"name": "Alisa B Busch",
"url": "https://questionsmedicales.fr/author/Alisa%20B%20Busch",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Care Policy, Harvard Medical School."
}
},
{
"@type": "Person",
"name": "Fang Zhang",
"url": "https://questionsmedicales.fr/author/Fang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Dennis Ross-Degnan",
"url": "https://questionsmedicales.fr/author/Dennis%20Ross-Degnan",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Mark K Meiselbach",
"url": "https://questionsmedicales.fr/author/Mark%20K%20Meiselbach",
"affiliation": {
"@type": "Organization",
"name": "Health Policy and Management, Johns Hopkins University, Baltimore, Maryland, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The roles of sensory hyperreactivity and hyporeactivity in understanding infant fearfulness and emerging autistic traits.",
"datePublished": "2024-01-03",
"url": "https://questionsmedicales.fr/article/38172076",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jcpp.13941"
}
},
{
"@type": "ScholarlyArticle",
"name": "Based on what parameters is safe to discontinuate inhaled corticosteroids in children with asthma?",
"datePublished": "2023-06-20",
"url": "https://questionsmedicales.fr/article/37262011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02770903.2023.2220795"
}
},
{
"@type": "ScholarlyArticle",
"name": "Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivity.",
"datePublished": "2024-03-26",
"url": "https://questionsmedicales.fr/article/38530239",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1084/jem.20231835"
}
},
{
"@type": "ScholarlyArticle",
"name": "No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.",
"datePublished": "2024-02-28",
"url": "https://questionsmedicales.fr/article/38417585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.rmed.2024.107581"
}
},
{
"@type": "ScholarlyArticle",
"name": "Asthma remission: what is it and how can it be achieved?",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/35361633",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1183/13993003.02583-2021"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Économie",
"item": "https://questionsmedicales.fr/mesh/D004467"
},
{
"@type": "ListItem",
"position": 4,
"name": "Financement organisé",
"item": "https://questionsmedicales.fr/mesh/D005381"
},
{
"@type": "ListItem",
"position": 5,
"name": "Assurance",
"item": "https://questionsmedicales.fr/mesh/D007341"
},
{
"@type": "ListItem",
"position": 6,
"name": "Participation aux coûts",
"item": "https://questionsmedicales.fr/mesh/D017047"
},
{
"@type": "ListItem",
"position": 7,
"name": "Franchises et coassurance",
"item": "https://questionsmedicales.fr/mesh/D003669"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Franchises et coassurance - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Franchises et coassurance",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Franchises et coassurance",
"description": "Qu'est-ce qu'une franchise en assurance santé ?\nComment fonctionne la coassurance ?\nQuelle est la différence entre franchise et coassurance ?\nComment sont calculées les franchises ?\nLes franchises sont-elles remboursables ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Franchises et coassurance",
"description": "Quels sont les impacts d'une franchise élevée ?\nComment la coassurance affecte-t-elle les patients ?\nLes patients ressentent-ils du stress à cause des franchises ?\nLes franchises influencent-elles la santé des patients ?\nY a-t-il des symptômes financiers liés à la coassurance ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Franchises et coassurance",
"description": "Comment éviter des frais élevés de franchise ?\nLes bilans de santé sont-ils couverts sans franchise ?\nComment éduquer les patients sur les franchises ?\nLes programmes de prévention réduisent-ils les coûts ?\nComment les patients peuvent-ils planifier leurs soins ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Franchises et coassurance",
"description": "Comment choisir un plan avec franchise ?\nLes traitements préventifs sont-ils couverts ?\nComment réduire les coûts de coassurance ?\nLes médicaments sont-ils soumis à la franchise ?\nLes soins d'urgence sont-ils affectés par la coassurance ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Franchises et coassurance",
"description": "Quelles complications peuvent survenir avec des franchises élevées ?\nLa coassurance peut-elle entraîner des complications financières ?\nLes patients évitent-ils des soins à cause des coûts ?\nComment les complications de santé affectent-elles les coûts ?\nLes complications dues à la coassurance sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Franchises et coassurance",
"description": "Quels facteurs augmentent les coûts de franchise ?\nComment le choix de l'assurance affecte-t-il les coûts ?\nLes maladies chroniques augmentent-elles les frais ?\nLes jeunes adultes ont-ils des franchises plus basses ?\nLes habitudes de santé influencent-elles les coûts ?",
"url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Bronchial+Hyperreactivity&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une franchise en assurance santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est le montant que le patient doit payer avant que l'assurance ne couvre les frais."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la coassurance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est le pourcentage des frais médicaux que le patient doit payer après la franchise."
}
},
{
"@type": "Question",
"name": "Quelle est la différence entre franchise et coassurance ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La franchise est un montant fixe, tandis que la coassurance est un pourcentage des frais."
}
},
{
"@type": "Question",
"name": "Comment sont calculées les franchises ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement fixées par le contrat d'assurance et varient selon les plans."
}
},
{
"@type": "Question",
"name": "Les franchises sont-elles remboursables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les montants de franchise ne sont pas remboursés par l'assurance."
}
},
{
"@type": "Question",
"name": "Quels sont les impacts d'une franchise élevée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une franchise élevée peut dissuader les patients de consulter des soins médicaux."
}
},
{
"@type": "Question",
"name": "Comment la coassurance affecte-t-elle les patients ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des coûts supplémentaires pour les patients lors de soins médicaux."
}
},
{
"@type": "Question",
"name": "Les patients ressentent-ils du stress à cause des franchises ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts imprévus peuvent causer de l'anxiété financière chez les patients."
}
},
{
"@type": "Question",
"name": "Les franchises influencent-elles la santé des patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent limiter l'accès aux soins, affectant ainsi la santé globale des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes financiers liés à la coassurance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des frais médicaux imprévus peuvent entraîner des difficultés financières."
}
},
{
"@type": "Question",
"name": "Comment éviter des frais élevés de franchise ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisissez un plan avec une franchise adaptée à vos besoins médicaux prévisibles."
}
},
{
"@type": "Question",
"name": "Les bilans de santé sont-ils couverts sans franchise ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les bilans de santé préventifs sont couverts sans frais de franchise."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les franchises ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournissez des informations claires sur les coûts et les options d'assurance disponibles."
}
},
{
"@type": "Question",
"name": "Les programmes de prévention réduisent-ils les coûts ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire les coûts à long terme en évitant des soins coûteux."
}
},
{
"@type": "Question",
"name": "Comment les patients peuvent-ils planifier leurs soins ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent évaluer leurs besoins et choisir des soins en fonction de leur plan d'assurance."
}
},
{
"@type": "Question",
"name": "Comment choisir un plan avec franchise ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluez vos besoins médicaux et comparez les coûts des franchises et coassurances."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils couverts ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les traitements préventifs sont couverts sans franchise, selon le plan."
}
},
{
"@type": "Question",
"name": "Comment réduire les coûts de coassurance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisissez des soins dans le réseau de votre assurance pour réduire les frais."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils soumis à la franchise ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent être soumis à la franchise selon le plan d'assurance."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils affectés par la coassurance ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les soins d'urgence peuvent entraîner des frais de coassurance après la franchise."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des franchises élevées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent retarder des soins nécessaires, entraînant des complications de santé."
}
},
{
"@type": "Question",
"name": "La coassurance peut-elle entraîner des complications financières ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des frais imprévus peuvent causer des dettes médicales importantes."
}
},
{
"@type": "Question",
"name": "Les patients évitent-ils des soins à cause des coûts ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts élevés peuvent dissuader les patients de rechercher des soins médicaux."
}
},
{
"@type": "Question",
"name": "Comment les complications de santé affectent-elles les coûts ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent entraîner des frais médicaux supplémentaires et imprévus."
}
},
{
"@type": "Question",
"name": "Les complications dues à la coassurance sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients rencontrent des difficultés à payer leurs frais médicaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les coûts de franchise ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents médicaux et le type de soins peuvent influencer les coûts."
}
},
{
"@type": "Question",
"name": "Comment le choix de l'assurance affecte-t-il les coûts ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Différents plans d'assurance ont des franchises et coassurances variées, influençant les coûts."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles les frais ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des maladies chroniques peuvent faire face à des frais plus élevés."
}
},
{
"@type": "Question",
"name": "Les jeunes adultes ont-ils des franchises plus basses ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les jeunes adultes choisissent des plans avec des franchises plus basses."
}
},
{
"@type": "Question",
"name": "Les habitudes de santé influencent-elles les coûts ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de santé positives peuvent réduire les frais médicaux à long terme."
}
}
]
}
]
}
Existing evidence indicates that atypical sensory reactivity is a core characteristic of autism, and has been linked to both anxiety (and its putative infant precursor of fearfulness) and repetitive b...
161 infants with and without an elevated likelihood of developing autism and attention-deficit hyperactivity disorder (ADHD) were followed from 10 to 36 months of age. Parents rated an infant precurso...
Hyperreactivity at 14 months was positively associated with fearfulness at 24 months, and hyperreactivity at 24 months was positively associated with SCI and RRB at 36 months. When hyporeactivity was ...
Our findings indicate that alterations in early sensory reactivity may increase the likelihood of showing fearfulness in infancy, and relate to later social interactions and repetitive behaviours, par...
Remission of childhood asthma has not been widely studied. Patients in clinical remission continue to have some degree of bronchial hyperresponsiveness (BHR). The aim of this study was to investigate ...
One year after discontinuation of inhaled corticosteroids (ICS), MCT was performed in a group of 40 asthmatic children to confirm or exclude BHR. In all patients, ICS treatment was discontinued based ...
Positive MCT was found in 50% of the patients. There was no statistically significant difference between the positive and negative MCT groups in age at initiation and discontinuation of ICS therapy, d...
Clinical parameters, normal spirometry, daily PEF values, and a negative bronchodilator test are good parameters for discontinuing ICS treatment in asthmatic children, even in patients with persistent...
Mechanosensitive ion channels sense force and pressure in immune cells to drive the inflammatory response in highly mechanical organs. Here, we report that Piezo1 channels repress group 2 innate lymph...
Although remission occur, childhood-onset asthma may persist until adulthood. Since few longitudinal population-based studies have followed a cohort from childhood until adulthood, the knowledge on pr...
To estimate persistence of asthma from 8 to 28 years and its associated factors....
Within the OLIN (Obstructive Lung Disease in Northern Sweden) studies, a cohort was recruited in 1996 (age 8y, n = 3430) and followed annually with questionnaires about asthma and risk factors until 1...
Of the 170 participants at 28y, 105 (61.8%) had persistent asthma (women: 49/76, 64.5%; men: 56/94, 59.6%, p = 0.513). Factors collected at recruitment: allergic sensitization (OR7.8, 95%CI 3.0-20.2),...
Among children with asthma onset by 8y, 62% still had asthma at age 28 years. Persistent asthma was associated with allergic sensitization, rhinoconjunctivitis, severe respiratory infection, a more se...
Asthma treatment goals currently focus on symptom and exacerbation control rather than remission. Remission is not identical to cure, but is a step closer. This review considers the current definition...
Irritant-induced asthma (IIA) is a phenotype of asthma caused by the inhalation of irritant agents. Definite, probable, or possible IIA have been described, depending on the concentration of the inhal...
Type 2 innate lymphoid cells (ILC2s) play a pivotal role in type 2 asthma. CD226 is a costimulatory molecule involved in various inflammatory diseases....
We aimed to investigate CD226 expression and function within human and mouse ILC2s, and to assess the impact of targeting CD226 on ILC2-mediated airway hyperreactivity (AHR)....
We administered IL-33 intranasally to wild-type mice, followed by treatment with anti-CD226 antibody or isotype control. Pulmonary ILC2s were sorted for ex vivo analyses through RNA sequencing and flo...
Our findings demonstrated an inducible expression of CD226 in activated ILC2s, enhancing their cytokine secretion and effector functions. Mechanistically, CD226 alters intracellular metabolism and enh...
Our findings underscore the potential of CD226 as a novel therapeutic target in ILC2s, presenting a promising avenue for ameliorating AHR and allergic asthma....
Essential hypertension (EHT) is characterized by cardiovascular hyperreactivity to stress but underlying mechanism are not fully understood. Here, we investigated the role of α-adrenergic receptors (α...
24 male HT and 24 male NT participated in three experimental trials on three separate days with a 1-min infusion followed by a 15-min infusion. Trials varied in infusion-substances: placebo saline (Sa...
SBP and DBP reactivity to the three infusion-trials differed between HT and NT (...
Our findings suggest a mediating role of α-AR in DBP hyperreactivity to NE-infusion in EHT. However, in SBP hyperreactivity to NE-infusion in EHT, the functioning of α-AR seems impaired suggesting tha...
Bronchial thermoplasty (BT) is a type of bronchoscopic treatment specifically used for patients with severe asthma. Most severe asthmatics receive systemic steroids and are at risk of being immunocomp...
Aging is an independent risk factor for the development of cardiovascular, thrombotic and other chronic diseases. However, mechanisms of platelet hyperactivation in aging remain poorly understood. Her...
Quantitative mass spectrometry with tandem mass tag (TMT) labeling systematically measured protein phosphorylation in platelets from healthy aged (>65 years) and young human (<45 years) subjects. The ...
Quantitative phosphoproteomics uncovered differential site-specific protein phosphorylation within mTOR, Rho GTPase and MAPK pathways in platelets from aged donors. Western blot confirmed constitutive...
Aging-related changes in mTOR phosphorylation enhance Rac1 and p38 activation, to enhance thromboxane generation, platelet hyperactivity and thrombosis....